drugset / Trial / NCT02571608

Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control

NCT02571608 ↗

Phase 4 Withdrawn McMaster University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Type II Diabetes Mellitus patients having surgery who adhere to their regular scheduled metformin dosing and take this medication on the morning of surgery will have better glycemic control peri-operatively and potentially suffer less morbidity compared to individuals taking a placebo.

Timeline

Start
2022-01-01
Primary completion
2022-12-31
Completion
2022-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “Study halted prematurely, prior to enrollment of first participant”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule — —